Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients.
about
The effect of targeted therapy on overall survival in advanced renal cancer: a study of the national surveillance epidemiology and end results registry databaseDisease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era.Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry.Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy erasTreatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008).Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy.Pazopanib in Metastatic Renal Cancer: A "Real-World" Experience at National Cancer Institute "Fondazione G. Pascale"Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study.A gap in disease-specific survival between younger and older adults with de novo metastatic renal cell carcinoma: results of a SEER database analysis.Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor.Intracrine androgen biosynthesis in renal cell carcinoma.Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice.High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis.
P2860
Q34081653-0C90B413-9F59-4810-B435-64CD127FCA35Q34713136-EAECD22C-50F7-4FB2-B5F5-86956E90C82FQ36384503-3E862A54-7B45-447C-9B88-4E5A6D47D6B5Q36528402-DC9B0CDB-684E-47EC-BBB1-8AA79F71AE8BQ36775359-FCF12BF1-8A00-4413-9A5E-436726F80111Q37012691-369380DE-5FDF-4622-84EE-DB3FE9330CF0Q37218304-8C0DC443-D046-478B-AAFA-C3EEFC9C07E0Q37596123-047FA4F1-33B8-4904-AE41-8D5A0F94811AQ37602881-40C91A17-01E4-422F-8EC2-FC8C8A49E54BQ37616807-15809B6C-003A-4DE0-AAEC-D89173F1DF45Q38110320-50550E81-A5DD-4F9B-AD72-A1A69DEE25E4Q38714201-0032B7F4-BD00-4A13-83A5-A62C3A06E608Q46627892-DABCCBD4-2B3F-45DE-8253-F1D5DB9C6A66Q52717618-04A39419-B230-4CF2-80E1-09D5FF6ECD1A
P2860
Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Epidemiologic trends in renal ...... y analysis of 28,252 patients.
@en
Epidemiologic trends in renal ...... y analysis of 28,252 patients.
@nl
type
label
Epidemiologic trends in renal ...... y analysis of 28,252 patients.
@en
Epidemiologic trends in renal ...... y analysis of 28,252 patients.
@nl
prefLabel
Epidemiologic trends in renal ...... y analysis of 28,252 patients.
@en
Epidemiologic trends in renal ...... y analysis of 28,252 patients.
@nl
P2093
P1476
Epidemiologic trends in renal ...... y analysis of 28,252 patients.
@en
P2093
Ann Brunson
Benjamin Tomlinson
Chong-Xian Pan
Derek Shek
Monica Brown
Primo N Lara
P356
10.1016/J.CLGC.2012.01.007
P407
P577
2012-02-28T00:00:00Z